DermSpot

DermSpot

World Class Algorithms

Our autonomous AI research expands the reach of dermatological care beyond the exam room, from skin cancer to inflammatory disease. We are currently recruiting pilot locations and research groups interested in skin diagnostics and management.

Join Us
spot image 1

* 3DermSpot is for Investigational Use Only

Latest News

3Derm Announces Two FDA Breakthrough Device Designations for Autonomous Skin Cancer AI

DermSpot* is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect melanoma, squamous cell carcinoma, and basal cell carcinoma.

DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.

Read the Press Release

Our Focus

We’re committed to using technology to increase access for all patients by focusing on high-impact disease areas and solutions

Diagnostic tools expedite and expand access to specialty care.
Diagnostic tools expedite and expand access to specialty care.
Chronic disease management supports remote patient monitoring.
Chronic disease management supports remote patient monitoring.
Life sciences applications enable trial and therapy monitoring.
Life sciences applications enable trial and therapy monitoring.
Melanoma icon

Melanoma

Melanoma is the most lethal form of skin cancer. If not caught early, there is high risk of it spreading from the skin to other tissues and parts of the body.

Basal icon

Basal Cell Carcinoma

Basal cell carcinoma is the most common form of skin cancer. BCC are slow growing and are highly curable when caught and treated early.

Squamous icon

Squamous Cell Carcinoma

Squamous cell carcinoma is a slow spreading cancer. When caught and treated early, SCC is highly curable.

Psoriasis icon

Psoriasis

Psoriasis is a chronic inflammatory skin condition. It can be managed through a variety of treatments, from topical steroids to biologics.

Dermatitis icon 1

Atopic Dermatitis

Atopic dermatitis, commonly referred to as eczema, is a chronic, itchy skin condition. It is typically treated by identifying triggers and/or moisturizing.

Learn more
spot image 2

Autonomous AI

Our research prioritizes safety, efficacy, and equity.

  • Clear decision making
  • Representative training data
  • Standardized imaging
  • Incorporation of clinical standards of care
spot image 3

No Automation Without Representation

We stand for technology that works for every skin tone.

Spot Image 7 cropped2
Spot Image 8 cropped2
Spot Image 9 cropped2
Learn More

Want to get involved?

Request More Information

DermSpot* FAQ

What is DermSpot?

DermSpot is an autonomous AI device under investigation by the FDA and is not currently authorized or available for sale. DermSpot is an algorithm that uses artificial intelligence (AI) and highly standardized skin images to autonomously detect the most common forms of skin cancer. DermSpot is being developed in collaboration with primary care physicians and dermatologists across the country.

What is autonomous AI?

Autonomous AI is a technology that can make clinical and diagnostic decisions that impact patient care without the need for physician involvement.